… synthetic disease-modifying antirheumatic drugs: a systematic literature review Informing
the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. …

… recommendations on RA treatment are not available. In this paper recommendations for
the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (…

… lives of the new biological anti-rheumatic drugs, there are certain recommendations—one
of … the recommendations used in Finland, but the details of such recommendations vary …

… To assess the efficacy and safety of synthetic disease-modifying antirheumatic drugs (DMARDs…
Rheumatism (EULAR) initiative to produce recommendations for the management of RA. …

… antirheumatic drugs (DMARDs) is better than initial monotherapy. FIN-RACo compared
sequential monotherapy with combination therapy. Saunders et al28 compared step-up therapy …

… Among the conventional synthetic (cs) disease-modifying antirheumatic drugs (DMARDs),12
we adopted methotrexate (MTX), on its optimal use, as the anchor drug4; in addition, a …

Objectives To review the evidence for the efficacy and safety of biological agents in patients
with rheumatoid arthritis (RA) to provide data to develop treatment recommendations by the …

… is to make recommendations for the perioperative management of antirheumatic treatment …
and non-biological disease-modifying antirheumatic drugs (DMARDs) had undergone surgery…

… ) recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological
disease-modifying antirheumatic drugs (… and grades of recommendations were derived …

… on the EULAR RA management recommendations with a sentence like: ‘With the current
rate of development, we expect an update of these recommendations to be necessary in about …